The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Phase II Study of Donepezil in Irradiated Brain Tumor Patients: Effect on Cognitive Function, Mood, and Quality of Life
Abstract
Purpose: A prospective, open-label phase II study was conducted to determine whether donepezil, a US Food and Drug Administration–approved reversible acetylcholinesterase inhibitor used to treat mild to moderate Alzheimer’s type dementia, improved cognitive functioning, mood, and quality of life (QOL) in irradiated brain tumor patients. Patients and Methods: Thirty-four patients received donepezil 5 mg/d for 6 weeks, then 10 mg/d for 18 weeks, followed by a washout period of 6 weeks off drug. Outcomes were assessed at baseline, 12, 24 (end of treatment), and 30 weeks (end of wash-out). All tests were administered by a trained research nurse. Results: Of 35 patients who initiated the study, 24 patients (mean age, 45 years) remained on study for 24 weeks and completed all outcome assessments. All 24 patients had a primary brain tumor, mostly low-grade glioma. Scores significantly improved between baseline (pretreatment) and week 24 on measures of attention/concentration, verbal memory, and figural memory and a trend for verbal fluency (all P < .05). Confused mood also improved from baseline to 24 weeks (P = .004), with a trend for fatigue and anger (all P < .05). Health-related QOL improved significantly from baseline to 24 weeks, particularly, for brain specific concerns with a trend for improvement in emotional and social functioning (all P < .05). Conclusion: Cognitive functioning, mood, and health-related QOL were significantly improved following a 24-week course of the acetylcholinesterase inhibitor donepezil. Toxicities were minimal. We are planning a double blinded, placebo-controlled, phase III trial of donepezil to confirm these favorable results.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Validity of the Trail Making Test as an Indicator of Organic Brain Damage
Reitan, R. M. (1958) · Perceptual and Motor Skills · doi:10.2466/pms.1958.8.3.271 · Cited by 7,928
Jemal, A., Murray, T., Ward, E., Samuels, A., Tiwari, R. C., Ghafoor, A., Feuer, E. J., & Thun, M. J. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.1.10 · Cited by 4,186
The clinical evaluation of chemotherapeutic agents in cancer
Karnofsky, D. A. (1949) · Medical Entomology and Zoology · Cited by 2,933
McNair, D. M. (1992) · Medical Entomology and Zoology · Cited by 2,692
Power and sample size calculations
Dupont, W. D., & Plummer, W. D. (1990) · Controlled Clinical Trials · doi:10.1016/0197-2456(90)90005-m · Cited by 2,092
Therapeutic irradiation and brain injury
Sheline, G. E., Wara, W. M., & Smith, V. (1980) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(80)90175-3 · Cited by 965
Treatment of Alzheimer's disease; current status and new perspectives
scarpini, E., Schelterns, P., & Feldman, H. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00502-7 · Cited by 721
Crossen, J. R., Garwood, D., Glatstein, E., & Neuwelt, E. A. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.3.627 · Cited by 721
Radiation response of the central nervous system
Schultheiss, T. E., Kun, L. E., Ang, K. K., & Stephens, L. C. (1995) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(94)00655-5 · Cited by 653
Meyers, C. A., Smith, J. A., Bezjak, A., Mehta, M. P., Liebmann, J., Illidge, T., Kunkler, I., Caudrelier, J.-M., Eisenberg, P. D., Meerwaldt, J., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.128 · Cited by 585
The Radioresponse of the Central Nervous System: A Dynamic Process
Tofilon, P. J., & Fike, J. R. (2000) · Radiation Research · doi:10.1667/0033-7587(2000)153[0357:trotcn]2.0.co;2 · Cited by 526
Methylphenidate therapy improves cognition, mood, and function of brain tumor patients.
Meyers, C. A., Weitzner, M. A., Valentine, A. D., & Levin, V. A. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.7.2522 · Cited by 377
Radiation induced CNS toxicity – molecular and cellular mechanisms
Belka, C., Budach, W., Kortmann, R. D., & Bamberg, M. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2100 · Cited by 301
Effects of treatment on long‐term survivors with malignant astrocytomas
Imperato, J. P., Paleologos, N. A., & Vick, N. A. (1990) · Annals of Neurology · doi:10.1002/ana.410280614 · Cited by 252
Brown, P. D., Buckner, J. C., O’Fallon, J. R., Iturria, N. L., Brown, C. A., O’Neill, B. P., Scheithauer, B. W., Dinapoli, R. P., Arusell, R. M., Curran, W. J., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.172 · Cited by 238
Self-citationDuffner, P. K. (2004) · The Neurologist · doi:10.1097/01.nrl.0000144287.35993.96 · Cited by 235
Meyers, C. A., & Hess, K. R. (2003) · Neuro-Oncology · doi:10.1093/neuonc/5.2.89 · Cited by 226
Fastenau, P. S., Denburg, N. L., & Hufford, B. J. (1999) · The Clinical Neuropsychologist · doi:10.1076/clin.13.1.30.1976 · Cited by 196
Scheibel, R., Meyers, C., & Levin, V. (1996) · Journal of Neuro-Oncology · doi:10.1007/bf00177444 · Cited by 194
Issues associated with repeated neuropsychological assessments
McCaffrey, R. J., & Westervelt, H. J. (1995) · Neuropsychology Review · doi:10.1007/bf02214762 · Cited by 171
Neuropsychologic impairment in astxocytoma survivors
Hochberg, F. H., & Slotnick, B. (1980) · Neurology · doi:10.1212/wnl.30.2.172 · Cited by 166
Cognitive functioning in long-term survivors of high-grade glioma
Archibald, Y. M., Lunn, D., Ruttan, L., Macdonald, D., Maestro, R. F. D., Barr, H. W. K., Pexman, J. H. W., Fisher, B. J., Gaspar, L. E., & Cairncross, J. G. (1994) · Journal of neurosurgery · doi:10.3171/jns.1994.80.2.0247 · Cited by 157
Cholinergic activity and amyloid precursor protein metabolism
Roberson, M. R., & Harrell, L. E. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00016-7 · Cited by 137
Bryson, H. M., & Benfield, P. (1997) · Drugs & Aging · doi:10.2165/00002512-199710030-00007 · Cited by 136
Armstrong, C. L., Ruffer, J. E., Corn, B. W., DeVries, K., & Mollman, J. E. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.9.2263 · Cited by 124
Capillary endothelium. Target site of renal radiation injury.
Jaenke, R. S., Robbins, M. E. C., Bywaters, T., Whitehouse, E. M., Rezvani, M., & Hopewell, J. W. (1993) · PubMed · Cited by 113
Self-citationLeukoencephalopathy in Small Cell Lung Cancer Patients Receiving Prophylactic Cranial Irradiation
Frytak, S., Shaw, J. N., O’Neill, B. P., et al. (1989) · American Journal of Clinical Oncology · doi:10.1097/00000421-198902000-00007 · Cited by 93
Grünberger, B., Wöhrer, S., Streubel, B., Formanek, M., Petkov, V., Puespoek, A., Häfner, M., Hejna, M., Jaeger, U., Chott, A., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.9025 · Cited by 86
Weitzner, M. A., Meyers, C. A., & Valentine, A. D. (1995) · Journal of Neuropsychiatry · doi:10.1176/jnp.7.3.347 · Cited by 84
Bottomley, A., Gaafa, R., Manegold, C., Burgers, S. J. A., Coens, C., Legrand, C., Vincent, M. D., Giaccone, G., & van Meerbeeck, J. P. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.3027 · Cited by 73
Hornsey, S., Myers, R., & Jenkinson, T. (1990) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(90)90319-f · Cited by 65
Recording neurological impairment in clinical trials of glioma
Grant, R., Slattery, J. M. A., Gregor, A., & Whittle, I. R. (1994) · Journal of Neuro-Oncology · doi:10.1007/bf01051047 · Cited by 62
Pharmacologic Modification of Radiation-Induced Late Normal Tissue Injury
Moulder, J. E., Robbins, M. E. C., Cohen, E. P., Hopewell, J. W., & Ward, W. F. (1998) · Cancer treatment and research · doi:10.1007/978-1-4615-5769-2_6 · Cited by 57
Self-citationThe Management of Radiation-Induced Brain Injury
Shaw, E. G., & Robbins, M. E. C. (2006) · Cancer treatment and research · doi:10.1007/0-387-25354-8_2 · Cited by 53
Self-citationEffects of X-irradiation on nerve growth factor in the developing mouse brain
Dimberg, Y., Vazquez, M. E., Söderström, S., & Ebendal, T. (1997) · Toxicology Letters · doi:10.1016/s0378-4274(96)03827-1 · Cited by 35
(1995) · doi:10.1002/1097-0142(19950301)75:5<1151::aid-cncr2820750515>3.0.co;2-q
Cited by
Wen, P. Y., & Kesari, S. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0708126 · Cited by 3,511
Brown, P. D., Pugh, S., Laack, N. N., Wefel, J. S., Khuntia, D., Meyers, C., Choucair, A., Fox, S., Suh, J. H., Roberge, D., et al. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not114 · Cited by 958
Breast cancer: pathogenesis and treatments
Xiong, X., Zheng, L.-W., Ding, Y., Chen, Y.-F., Cai, Y.-W., Wang, L.-P., Huang, L., Liu, C.-C., Shao, Z.-M., & Yu, K.-D. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02108-4 · Cited by 958
Radiation-induced brain injury: A review
Greene-Schloesser, D., Robbins, M. E., Peiffer, A. M., Shaw, E. G., Wheeler, K. T., & Chan, M. D. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00073 · Cited by 700
Self-citationErbB receptors: from oncogenes to targeted cancer therapies
Zhang, H., Berezov, A., Wang, Q., Zhang, G., Drebin, J., Murali, R., & Greene, M. I. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32278 · Cited by 574
Metadata
- Authors
- Shaw, E. G., Rosdhal, R., D'Agostino, R. B., Lovato, J., Naughton, M. J., Robbins, M. E., & Rapp, S. R.
- Venue
- Journal of Clinical Oncology
- Published
- 2006-03-20
- Volume
- 24
- Issue
- 9
- Pages
- 1415-1420
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2104220103
- Cited by
- 326
- References
- 37
- FWCI
- 17.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.